Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Gilead Sciences, Inc shares valued at $23,065,271 were sold by Dickinson Andrew D on Nov 29 ’24. At $92.76 per share, Dickinson Andrew D sold 248,645 shares. The insider’s holdings dropped to 138,919 shares worth approximately $12.97 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Parsey Merdad sold 164,211 shares, netting a total of over 15,094,013 in proceeds. Following the sale of shares at $91.92 each, the insider now holds 80,801 shares.
Before that, ANDREW DICKINSON had added 248,645 shares to its account. In a trade valued at $23,065,258, the Officer bought Gilead Sciences, Inc shares for $92.76 each.
As published in their initiating research note from Wolfe Research on November 15, 2024, Gilead Sciences, Inc [GILD] has been an Outperform and the price target has been revised to $110. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in mid November. As of November 08, 2024, Maxim Group has decreased its “Buy” rating to a “Hold” for GILD. Earlier on October 21, 2024, Leerink Partners upgraded its rating. Their new recommendation was “an Outperform” for GILD stock which previously was a “a Market perform”.
Analyzing GILD Stock Performance
During the last five days, there has been a surge of approximately 1.06%. Over the course of the year, Gilead Sciences, Inc shares have jumped approximately 15.28%. Shares of the company reached a 52-week high of $98.90 on 11/11/24 and a 52-week low of $62.07 on 05/31/24. A 50-day SMA is recorded $88.84, while a 200-day SMA reached $75.93. Nevertheless, trading volume fell to 11.28 million shares from 0.18 million shares the previous day.
Support And Resistance Levels for Gilead Sciences, Inc (GILD)
According to the 24-hour chart, there is a support level at 91.90, which, if violated, would cause prices to drop to 90.42. In the upper region, resistance lies at 94.57. The next price resistance is at 95.76. RSI (Relative Strength Index) is 58.93 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.67, which suggests the price will increase in the coming days. Percent R is at 12.03%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
